Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.05 USD | -4.54% | -0.20% | +11.73% |
09/05 | Earnings Flash (PRPH) PROPHASE LABS Posts Q1 Revenue $3.6M, vs. Street Est of $9.9M | MT |
09/05 | Transcript : ProPhase Labs, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Sales 2024 * | 47.06M 3.93B | Sales 2025 * | 138M 11.54B | Capitalization | 95.46M 7.97B |
---|---|---|---|---|---|
Net income 2024 * | -17M -1.42B | Net income 2025 * | 11M 918M | EV / Sales 2024 * | 2.03 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.69 x |
P/E ratio 2024 * |
-5.73
x | P/E ratio 2025 * |
11
x | Employees | 113 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 36.99% |
Latest transcript on ProPhase Labs, Inc.
1 day | +4.75% | ||
1 week | -0.94% | ||
Current month | +14.75% | ||
1 month | -18.87% | ||
3 months | +7.52% | ||
6 months | +16.65% | ||
Current year | +17.04% |
Managers | Title | Age | Since |
---|---|---|---|
Ted Karkus
CEO | Chief Executive Officer | 64 | 15/09/15 |
Chief Operating Officer | 50 | 01/01 | |
Robert Morse
AUD | Comptroller/Controller/Auditor | 49 | 01/22/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Louis Gleckel
BRD | Director/Board Member | 68 | 01/09/01 |
Ted Karkus
CEO | Chief Executive Officer | 64 | 15/09/15 |
Jason Barr
BRD | Director/Board Member | 44 | 01/15/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.20% | 25 M€ | -2.33% | - |
Date | Price | Change | Volume |
---|---|---|---|
14/24/14 | 5.05 | -4.54% | 15 272 |
13/24/13 | 5.29 | +4.75% | 48,076 |
10/24/10 | 5.05 | +2.64% | 32,777 |
09/24/09 | 4.92 | -8.72% | 71,139 |
08/24/08 | 5.39 | +6.52% | 57,288 |
Delayed Quote Nasdaq, May 14, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.04% | 95.46M | |
-13.90% | 8.58B | |
+60.25% | 4.12B | |
-43.01% | 2.29B | |
-9.98% | 2.44B | |
-3.01% | 2.48B | |
-3.40% | 2B | |
-19.79% | 1.53B | |
-40.57% | 1.21B | |
+9.11% | 1.12B |
- Stock Market
- Equities
- PRPH Stock